David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
Bud BilanichSuccess Coach
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Joey CohenMedication Adherence
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
WALTHAM, Mass., Nov. 02, 2016 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or ...
– 91% CR+CRi/CRp Rate in Ivosidenib-treated Patients with De Novo AML and 53% in Ivosidenib-treated ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email